Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications

Biochim Biophys Acta. 1991 May 8;1083(2):139-46. doi: 10.1016/0005-2760(91)90034-f.

Abstract

The stability of apolipoprotein E/lipoprotein associations has been examined as a function of apolipoprotein E phenotype. Visualisation by immunoblotting showed plasma apolipoprotein E to be present in two forms; the free form and, as previously described, an E-A-II complex. In very low density lipoproteins isolated by gel filtration from subjects with E3/3 and E4/3 phenotypes, apolipoprotein E was present essentially in the free form (ratio free: complex of 12.2 and 37.5, respectively). Exploiting ultracentrifugation as the disruptive agent, very-low-density lipoproteins thus isolated were shown to have substantially lower ratios (5.6 and 5.4, respectively) reflecting preferential loss of free apolipoprotein E. In high-density lipoproteins isolated by gel filtration from E3/3 phenotypes, apolipoprotein E was largely present as an E-A-II complex (80.3%). In contrast, the majority of apolipoprotein E in high-density lipoproteins from E4/3 phenotypes was present in the free form (58.7%). In both phenotypes, the content of free apolipoprotein E was markedly reduced by ultracentrifugation. The results confirm the notion that the formation of the E-A-II complex is a major determinant of the stability of apolipoprotein E-high-density lipoprotein associations. Moreover, that the predominant, ancestral isoform, apolipoprotein E3, exists largely as an E-A-II complex in higher density lipoproteins has important functional implications for this plasma source of apolipoprotein E.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Apolipoprotein A-II
  • Apolipoproteins A / blood*
  • Apolipoproteins A / chemistry
  • Apolipoproteins E / blood*
  • Apolipoproteins E / chemistry
  • Binding, Competitive
  • Blotting, Western
  • Centrifugation, Density Gradient
  • Chromatography, Gel
  • Fibroblasts / metabolism
  • Humans
  • Immunosorbent Techniques
  • In Vitro Techniques
  • Lipoproteins, HDL / blood
  • Lipoproteins, HDL / chemistry*
  • Lipoproteins, LDL / metabolism
  • Lipoproteins, VLDL / blood
  • Lipoproteins, VLDL / chemistry*
  • Phenotype
  • Protein Binding

Substances

  • Antibodies, Monoclonal
  • Apolipoprotein A-II
  • Apolipoproteins A
  • Apolipoproteins E
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Lipoproteins, VLDL